In the period 1985-1995, 87 @entity1 underwent surgery for @entity3969 ; 16 were lost to follow-up. Of the remaining @entity1 , 27 presented with stage I disease, 11 with stage II, 12 with stage III, 14 with stage IV, and 6 with stage V. One @entity1 was not staged. The histology was favourable @entity3969 in 44, anaplastic in 12, unclassified in 8, clear-cell @entity242 in 4, and @entity5 in 3. Although a total nephrectomy was generally performed, partial renal surgery was performed for 6 bilateral and 4 @entity5 , the latter including 2 @entity8 . Preoperative chemotherapy was employed with benefit in massive @entity5 , @entity5 in @entity8 , @entity5 , and preoperatively diagnosed @entity5 thrombi. Postoperative chemotherapy, employed in all cases, consisted of @entity4316 and @entity1891 with the addition of @entity632 in anaplastic and @entity5 . Ten @entity1 underwent second-line chemotherapy for disease unresponsive to the above management, but only 1 of these is currently free of disease. @entity5 -bed radiotherapy, used in selected cases, prevented local recurrence in stage I and II disease. However, 20% of stage I and II @entity1 not receiving radiotherapy developed @entity5 -bed recurrence. Twenty-three @entity1 have died and 5 with @entity1442 and incomplete follow-up are presumed to be dead. Nine @entity1 are currently on treatment; 34 have successfully completed treatment, the disease-free survival in stages I-V being 81%, 75%, 42%, 14%, and 50%, respectively. Overall disease-free survival was 69% for @entity3969 of favourable histology and 50% for @entity5 . The 3 @entity1 with @entity5 and 3 of 4 with clear-cell @entity242 have died. @entity3969 management in the developing world is compromised by cases lost to follow-up and late presentation with massive @entity5 and advanced stage. Preoperative chemotherapy is advantageous in a number of cases, and postoperative radiotherapy should be deployed more frequently.

Results of XXXX management in two tertiary-care hospitals in Asia.

@entity1 :: ('9606', 'Species') :: ['child', 'children', 'patients'] @entity632 :: ('MESH:D004317', 'Chemical') :: ['adriamycin'] @entity8 :: ('MESH:D007674', 'Disease') :: ['fused kidneys'] @entity242 :: ('MESH:D012509', 'Disease') :: ['sarcoma', 'sarcomas'] @entity5 :: ('MESH:D009369', 'Disease') :: ['rhabdoid tumours', 'inferior vena caval tumour', 'anaplastic tumours', 'tumour', 'unilateral tumours', 'tumours', 'rhabdoid tumour', 'advanced-stage tumours', 'Postoperative tumour', 'bilateral tumours'] @entity4316 :: ('MESH:D003609', 'Chemical') :: ['actinomycin D'] @entity1442 :: ('MESH:D020178', 'Disease') :: ['advanced disease'] @entity1891 :: ('MESH:D014750', 'Chemical') :: ['vincristine'] @entity3969 :: ('MESH:D009396', 'Disease') :: ["Wilms' tumour"]
@entity3969 :: (MESH:D009396,Disease) :: ['Wilms' tumour']
